ELRAY RESOURCES, INC. - 27 Dec 2024 Form 3 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
10%+ Owner
Signature
Elray Resources, Inc., by /s/ Anthony Brian Goodman, CEO
Issuer symbol
ATNF
Transactions as of
27 Dec 2024
Net transactions value
$0
Form type
3
Filing time
31 Dec 2024, 07:55:21 UTC
Next filing
11 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATNF Series B Convertible Preferred Stock 27 Dec 2024 Common Stock 1,318,000 Direct F1, F2, F3
holding ATNF Common Stock Purchase Warrants 27 Dec 2024 Common Stock 3,000,000 $1.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The conversion of the Series B Convertible Preferred Stock and exercise of the warrants was subject to shareholder approval, which shareholder approval was received on December 27, 2024.
F2 The Series B Convertible Preferred Stock has no expiration date. The Series B Convertible Preferred Stock is described in greater detail in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on October 3, 2024.
F3 Each of the 1,000,000 shares of Series B Convertible Preferred Stock is convertible into 1.318 shares of common stock.